The short version of RP-HPLC fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-09-27. Anything still debated is marked as such rather than presented as settled.
Tirzepatide is a synthetic peptide of 39 amino acids engineered from the native glucose-dependent insulinotropic polypeptide sequence. Its structure incorporates several non-natural residues and a C-terminal segment derived from glucagon-like peptide-1, together with a C20 fatty diacid moiety attached through a linker. The lipophilic side chain promotes binding to serum albumin, which slows renal clearance after administration. The compound is classified as a dual incretin receptor agonist and is supplied as a lyophilized powder for reconstitution or as a preformulated solution, depending on the presentation.
The peptide activates two G protein-coupled receptors, GIPR and GLP-1R. Binding triggers adenylyl cyclase activity and raises intracellular cyclic AMP in pancreatic beta cells, which potentiates insulin release when glucose is elevated. Signaling in the central nervous system is associated with reduced appetite and lower energy intake, while effects on gastric emptying and glucagon secretion are also reported. Because activity at both receptors is retained, the pharmacological profile is often described as incretin-based rather than selective for a single receptor.
The compound first appeared in the scientific literature as an investigational agent for type 2 diabetes. Clinical development proceeded through phase 1, phase 2, and phase 3 programs that measured glycemic control as a primary endpoint while recording body weight as a secondary outcome. Regulatory approval in the United States followed in 2022 for glycemic control, and a separate indication for chronic weight management was added later. Subsequent trials have examined cardiovascular outcomes in adults with elevated cardiovascular risk. Debates continue over how much of the observed effect derives from each receptor arm.
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
Tirzepatide is a synthetic peptide composed of 39 amino acids. It acts as a dual agonist at two incretin receptors, the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. The molecule was designed by modifying the native sequence of glucose-dependent insulinotropic polypeptide to improve metabolic stability and extend its circulation time. Its structure includes several non-natural amino acid residues and a fatty acid side chain. These features distinguish it from earlier single-receptor incretin analogs studied in the same period.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Approximate composition of the free peptide |
| Molecular weight | Approximately 4813 Da | Calculated for the free base |
| Structural class | Synthetic linear peptide | 39 residues with modified backbone |
| Solubility | Soluble in water and polar solvents | Behavior of the lyophilized solid |
| Typical storage temperature | -20 degrees Celsius or below | Solid form, protected from light |
Reported outcomes in large trials include dose-dependent weight reduction and improvements in glycemic markers over periods ranging from several months to more than a year. Whether the compound alters long-term cardiovascular or renal outcomes is being examined in dedicated outcome studies, so those questions remain open. Labeling describes gastrointestinal effects such as nausea and diarrhea, which tend to appear during dose escalation. Discontinuation rates and the durability of effects after treatment stops vary across study populations and are still debated.
Tirzepatide is a synthetic peptide developed as a dual agonist at the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors. Its structure is built on a GIP-derived backbone with non-natural amino acid substitutions and a fatty diacid side chain that promotes albumin binding and slows clearance. That modification supports once-weekly subcutaneous dosing. Registrational trial programs reported reductions in body weight and glycated hemoglobin alongside the drug's glycemic effects.
Both receptors are class B G protein-coupled receptors that signal largely through Gs-mediated cyclic AMP production. Activation within pancreatic islets increases glucose-dependent insulin secretion and suppresses glucagon release when glucose is elevated. Outside the pancreas, signaling in the central nervous system and gut appears to influence appetite and gastric emptying. The relative contribution of each receptor to observed clinical effects remains under investigation, and the two pathways are not simply additive in practice.
Regulatory and quality discussions place the peptide within established guidance for synthetic peptides and biologics. Forced degradation studies, in which samples are exposed to heat, acid, base, peroxide, and light, identify likely degradation products and validate the selectivity of analytical methods. Reference standards allow comparison across laboratories and production batches. Purity specifications reported in the literature usually combine chromatographic purity with mass confirmation. Which impurity thresholds are meaningful for long-term behavior is still debated, and no single universal specification has been adopted across all jurisdictions.
Routine characterization of the peptide relies on reversed-phase high-performance liquid chromatography for purity assessment, usually with ultraviolet detection near 214 nanometers. Intact mass measurement by liquid chromatography coupled to mass spectrometry confirms molecular identity against a theoretical value. Sequence-level confirmation uses enzymatic digestion followed by tandem mass spectrometry, an approach known as peptide mapping. Amino acid analysis gives an independent check on composition. Circular dichroism spectra are used to estimate helical content in aqueous buffer.
Degradation pathways for tirzepatide include deamidation, oxidation, and aggregation, which are common for therapeutic peptides. These processes can be monitored by size-exclusion chromatography (SEC) for aggregates and ion-exchange chromatography for charge variants. Forced degradation studies under acidic, basic, oxidative, and thermal stress help identify potential impurities. The exact stability profile depends on formulation, concentration, and container-closure system.
Analytical characterization of tirzepatide typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) for purity assessment and peptide mapping. Mass spectrometry, often coupled with electrospray ionization, confirms molecular weight and sequence integrity. Amino acid analysis and capillary electrophoresis may also be used to detect impurities or degradation products. These methods are essential for batch release and stability studies.
Storage recommendations for tirzepatide generally specify refrigeration at 2–8 °C to maintain stability. The peptide should be protected from light and kept in its original packaging to prevent aggregation or adsorption. Freezing is not recommended because freeze-thaw cycles can cause aggregation or precipitation. Once dispensed, storage conditions and in-use periods follow product-specific labeling, which may allow room temperature storage for a limited time.
Clinical research programs have evaluated tirzepatide in adults with type 2 diabetes and in adults with obesity or excess weight. Trials generally reported reductions in glycated hemoglobin and body weight across treatment periods of several months. Since these studies enrolled defined populations under controlled conditions, the findings describe group averages rather than individual outcomes. Open questions include the durability of effects after treatment stops, variation among subgroups, and the long-term consequences of sustained dual receptor stimulation. Published trial summaries should be consulted for exact measurements rather than secondary accounts.
Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its backbone derives from the native glucose-dependent insulinotropic polypeptide sequence, altered at several positions to resist enzymatic cleavage. A fatty diacid group attached through a linker extends plasma residence time by promoting reversible binding to serum albumin. The molecule carries a net negative charge near physiological pH and has a reported molecular weight close to 4813 daltons. These features separate it from shorter incretin analogs and account for its prolonged dosing interval.
Pharmacologically, tirzepatide activates two distinct G protein-coupled receptors: the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. Binding at each target triggers cyclic AMP accumulation and downstream signaling in pancreatic beta cells, adipose tissue and the central nervous system. Because the two pathways overlap only partially, the combined effect on insulin secretion, glucagon suppression and appetite signaling differs from that of selective single-receptor compounds. Affinity is not equal across the two targets, and the clinical meaning of that imbalance remains an area of active study.
=== Electrospray ionization mass spectrometry === Electrospray ionization mass spectrometry is a very versatile technique, consisting in a transfer of the formed complexes from the injected solution to the gas phase by a soft ionization process without strongly perturbing the complex stability. In addition, a small amount of the prepared solution needs to be injected to obtain the speciation spectra. Speciation of several metal ions can be investigated in monophasic solutions at increasing ligand concentration in order to explore all potential complexes. Collision Induced Dissociation (CID) analysis can be also performed to assess the kinetic stability of the formed complexes by discovering the main fragmentation pathway of the ligand. Besides, the protonation effect on the complexation mechanism can be observed by performing analysis on monophasic solutions at increasing nitric acid concentration. Corroboration of the major complexes involved into the extraction process is generally found by performing experiments on biphasic solutions upon extraction tests. Despite versatility of this spectroscopic technique that directly provides information by changing the ligand to metal ratios, its qualitative nature due to instrumental set-up and potential changes in solution chemistry could partially affect species distribution and its ion abundance. For these reasons, corroboration for the speciation results needs to be found by other spectroscopic techniques.
The first document, which was leaked at the end of January, was a "draft version of the Progressive Conservative government's upcoming health-care transformation legislation." CTV News said "local health integration networks, Cancer Care Ontario, eHealth Ontario, the Trillium Gift of Life Network and other government health agencies" would be "rolled into" the super agency. Minister Elliot said that the December 13 assistant deputy ministers workshop document, which made references to outsourcing laboratories, "inspections, licensing, devices" and Ornge, were options and that these services would not be privatized. The NDP said that the super agency was described in the leaked documents as having the "competency and capacity to effectively partner with public and private sector entities." The documents show that MyCare groups is being created as a "new model" of "integrated care delivery" with the goal of providing "patients with seamless, co-ordinated care and a single team of providers for all their care needs." Ontario Health Minister Christine Elliot tabled the controversial Bill 74: The People's Health Care Act. Its first reading was on February 26, 2019, and it received Royal Assent on April 18, 2019.
== Scholarly works == Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis, Published in Travel Medicine and Infectious Disease, Volume 34, March–April 2020 Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), Published in The Journal of Medical Virology, Volume 92 Issue 7, July 2020 Probable Zoonotic Leprosy in the Southern United States, Published in the New England Journal of Medicine, April 28, 2011. ChikDenMaZika Syndrome: the challenge of diagnosing arboviral infections in the midst of concurrent epidemics, Published in Annals of Clinical Microbiology and Antimicrobials, Article 42, July 22, 2016. Lobomycosis in Venezuela, Published in the International Journal of Dermatology, Volume 46, Issue 22, February 2007. Venezuela's humanitarian crisis, resurgence of vector-borne diseases, and implications for spillover in the region, Published in The Lancet, Volume 19, Issue 5, May 2019.
== Research contributions == Balalaie's research focuses on several areas of organic chemistry, including environmentally friendly synthetic methods and pharmaceutical applications. His research group has worked on the development of multicomponent reactions (MCRs), particularly for the synthesis of heterocyclic compounds. His work in this area has included the use of zeolite catalysts for the preparation of tetrasubstituted imidazoles and other heterocycles. His research has also involved developing synthetic routes for several active pharmaceutical ingredients (APIs). Compounds published by his group include: Zoledronic acid, Gabapentin, Deferasirox and Pantoprazole. In peptide synthesis, Balalaie's work has included the synthesis of therapeutic peptides such as triptorelin, leuprolide, octreotide, and oxytocin. His group has also designed cyclopeptides containing heterocyclic structures (imidazole, thiazole, oxazole) intended to serve as potential anticancer agents. His book "Peptide Chemistry in Persian" was recognized as a winner of the Iran Book of the Year Award in 1399 (2020).
Sources: en.wikipedia.org
Typically, the base for lean is a strong prescription cold medicine, specifically cough syrup that contains both promethazine and codeine. Other preparations use codeine/guaifenasin, hydrocodone/chlorphenamine, hydrocodone/APAP, and hydrocodone/homatropine. Over-the-counter cold medicines that contain dextromethorphan (often paired with guaifenasin or acetaminophen) as the active ingredient have also been used, as they do not require acquiring a prescription. To create a drinkable mixture, the cough syrup is combined with soft drinks, especially fruit-flavored drinks such as Sprite, Mountain Dew, or Fanta, and is often served in foam cups. A hard candy, usually a Jolly Rancher, may be added to give the mixture a sweeter flavor. Masking the undesired taste may impair judgment of the potency, which is a factor in overdosing.
=== Other Pacific nations === Several governments of Pacific nations, including Samoa, Fiji, Vanuatu, and Papua New Guinea, publicly reported by the end of March that they had enough fuel reserves to continue operating for a few months. However, some officials have privately expressed concerns about the future if oil deliveries to the region are halted owing to the war, and prices have gone up in all of these countries as well as Solomon Islands, Tonga, and Marshall Islands. Officials in Samoa, Cook Islands and Fiji have warned citizens against panic buying and hoarding. Australian Foreign Minister Penny Wong and Minister for Pacific Island Affairs Pat Conroy have signalled their willingness to ensure that regional neighbours do not run out of fuel. The New Zealand Government stated that it was assessing how it could help the Pacific region, particularly the Polynesian nations. Due to rising fuel costs, Air New Zealand has cancelled 1,100 flights in the Pacific region, affecting around 44,000 passengers.
== Macquarie Dictionary == The Macquarie Dictionary, which is the dictionary of Australian English, updates the online dictionary each year with new words, phrases, and definitions. These can be viewed on their website. Each year the editors review all new words and definitions that have been added to the dictionary in the past year from which they select a shortlist and invite the public to vote on their favourite. The public vote is held in November and results in the People's Choice winner. The most influential word of the year is also selected by the Word of the Year Committee which comprises the Editorial Team at Macquarie Dictionary along with David Astle and language research specialist Tiger Webb. The Committee meets annually to select the overall winning words. The following is the list of winning words since the Macquarie Word of the Year first began in 2006:
=== Toxicity === Iron is also potentially toxic. Its ability to donate and accept electrons means that it can catalyze the conversion of hydrogen peroxide into free radicals. Free radicals can cause damage to a wide variety of cellular structures, and ultimately kill the cell. Iron bound to proteins or cofactors such as heme is safe. Also, there are virtually no truly free iron ions in the cell, since they readily form complexes with organic molecules. However, some of the intracellular iron is bound to low-affinity complexes, and is termed labile iron or "free" iron. Iron in such complexes can cause damage as described above. To prevent that kind of damage, all life forms that use iron bind the iron atoms to proteins. This binding allows cells to benefit from iron while also limiting its ability to do harm. Typical intracellular labile iron concentrations in bacteria are 10–20 micromolar, though they can be 10-fold higher in anaerobic environment, where free radicals and reactive oxygen species are scarcer. In mammalian cells, intracellular labile iron concentrations are typically smaller than 1 micromolar, less than 5 percent of total cellular iron.
Apollo 11 left lunar orbit and returned to Earth, landing safely in the Pacific Ocean on July 24, 1969. When the spacecraft splashed down, 2,982 days had passed since Kennedy's commitment to landing a man on the Moon and returning him safely to the Earth before the end of the decade; the mission was completed with 161 days to spare. With the safe completion of the Apollo 11 mission, the Americans won the race to the Moon. Armstrong and his crew became worldwide celebrities, feted with ticker-tape parades on August 13 in New York City and Chicago, attended by an estimated six million. That evening in Los Angeles they were honored at an official state dinner attended by members of Congress, 44 governors, the Chief Justice of the United States, and ambassadors from 83 nations. The President and Vice president presented each astronaut with the Presidential Medal of Freedom. The astronauts spoke before a joint session of Congress on September 16, 1969. This began a 38-day world tour to 22 foreign countries and included visits with the leaders of many countries. The public's reaction in the Soviet Union was mixed. The Soviet government limited the release of information about the lunar landing, which affected the reaction. A portion of the populace did not give it any attention, and another portion was angered by it. The first landing was followed by another, precision landing on Apollo 12 in November 1969, within walking distance of the Surveyor 3 spacecraft which landed on April 20, 1967.
Sources: en.wikipedia.org
Cephalopods are widely regarded as the most intelligent of the invertebrates and have well-developed senses and large brains (larger than those of gastropods). The nervous system of cephalopods is the most complex of the invertebrates and their brain-to-body-mass ratio falls between that of endothermic and ectothermic vertebrates. Captive cephalopods have been known to climb out of their aquaria, maneuver a distance of the lab floor, enter another aquarium to feed on captive crabs, and return to their own aquarium. The brain is protected in a cartilaginous cranium. The giant nerve fibers of the cephalopod mantle have been widely used for many years as experimental material in neurophysiology; their large diameter (due to lack of myelination) makes them relatively easy to study compared with other animals. Many cephalopods are social creatures; when isolated from their own kind, some species have been observed shoaling with fish. Some cephalopods are able to fly through the air for distances of up to 50 metres (160 ft). While cephalopods are not particularly aerodynamic, they achieve these impressive ranges by jet-propulsion; water continues to be expelled from the funnel while the organism is in the air. The animals spread their fins and tentacles to form wings and actively control lift force with body posture. One species, Todarodes pacificus, has been observed spreading tentacles in a flat fan shape with a mucus film between the individual tentacles, while another, Sepioteuthis sepioidea, has been observed putting the tentacles in a circular arrangement.
== Family reconstitution == Untainted by Nazi associations, a French demographer, Louis Henry (1911–1991), was developing methods in France to survey historic populations. His 1956 book co-written with Michel Fleury, Des registres paroissiaux à l'histoire de la population. Manuel de dépouillement et d'exploitation de l'état civil ancien, explained how to start a one-place study. By 1959 he was proposing to reconstitute the population of France from 1670 to 1829. As a founder of Historical demography, Henry devised methods that went well beyond mere extraction, and he developed elaborate rules to correct bias and indicate which family histories could be used for different kinds of statistical analysis. In England, family reconstitution methods were adopted and developed by the Cambridge Group for the History of Population and Social Structure established in 1964. Amateur one-place studies followed in the 1980s as an outgrowth of indexing projects under the leadership of John Dowding and Colin Mills and achieved regional scale with the Devon Online Parish Clerks and One-Place Studies project. The fact that seven censuses from 1841 to 1901 provide a household-by-household record of the entire population may have reduced the perceived need in Britain for one-place studies compared to the interest they have generated in Germany and France. Many English studies therefore concentrate on the period before 1837, the year when open-access, national indexes of births, marriages and deaths in England and Wales began.[3]
=== Modern standard === Third generation TSH assay is the requirement for modern standards of care. TSH testing in the United States is typically carried out with automated platforms using advanced forms of immunometric assay. Nonetheless, there is no international standard for measurement of thyroid-stimulating hormone.
== External links == "Cyanogen Bromide MSDS Number: C6600". J. T. Baker. 1996-08-12. Teeri, A. E. (1948). "Thiamine and the Cyanogen Bromide Reaction". Journal of Biological Chemistry. 173 (2): 503–505. doi:10.1016/S0021-9258(18)57422-6. PMID 18910706.
Like other cephalopods, octopuses have camera-like eyes. Colour vision appears to vary from species to species, for example, it is present in A. aegina but absent in O. vulgaris. Opsins in the skin respond to different wavelengths of light and help the animals choose a colouration that matches the surroundings and camouflages them; chromatophores in the skin can respond to light independently of the eyes. An alternative hypothesis is that cephalopod eyes in species that only have a single photoreceptor protein may use chromatic aberration to turn monochromatic vision into colour vision, though this lowers image quality. This would explain pupils shaped like the letter "U", the letter "W", or a dumbbell, as well as the need for colourful mating displays. Attached to the optic capsules are two organs called statocysts (sac-like structures containing a mineralised mass and sensitive hairs), that allow the octopus to sense the orientation of its body, relative to both gravity and time (angular acceleration). An autonomic response keeps the octopus's eyes oriented so that the pupil is always horizontal. Octopuses may also use the statocyst to hear. The common octopus can hear sounds between 400 Hz and 1000 Hz, and hears best at 600 Hz. Octopuses have an excellent somatosensory system. Their suction cups are equipped with chemoreceptors so they can taste what they touch. Octopus arms move easily because the sensors recognise octopus skin and prevent self-attachment. Octopuses appear to have poor proprioceptive sense and must see their arms to keep track of their position.
Sources: en.wikipedia.org
It is a synthetic linear peptide that acts as a dual agonist at the GIP and GLP-1 receptors. It combines a modified incretin backbone with a fatty diacid side chain that extends its circulation time. It is not a small-molecule drug and is not orally absorbed in its native form.
Single-receptor agents act predominantly at GLP-1R. Tirzepatide retains activity at GIPR, which is expressed in pancreatic islets, adipose tissue, and the central nervous system. The contribution of each receptor to the overall response is still an area of active study, and the relative weight of GIPR signaling in humans is not fully settled.
The fatty diacid moiety binds serum albumin, which reduces renal filtration of the active peptide. Additional resistance to enzymatic breakdown comes from non-natural residues in the backbone. Together these features produce an apparent half-life of about five days and permit weekly dosing intervals.
It activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. This dual activity separates it from agents that act on only one of the two receptors. The relative contribution of each receptor to clinical effects remains an open area of study.